Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation
dc.contributor.author | Xu, X | |
dc.contributor.author | Gao, D | |
dc.contributor.author | Wang, P | |
dc.contributor.author | Chen, J | |
dc.contributor.author | Ruan, J | |
dc.contributor.author | Xu, J | |
dc.contributor.author | Xia, X | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2022-10-05T15:00:17Z | |
dc.date.available | 2022-10-05T15:00:17Z | |
dc.date.issued | 2018-12-01 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/30076383 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/174901 | en |
dc.description.abstract | CRISPR/Cas9 efficiently generates gene knock-out via nonhomologous end joining (NHEJ), but the efficiency of precise homology-directed repair (HDR) is substantially lower, especially in the hard-to-transfect human stem cells and primary cells. Herein we report a tube electroporation method that can effectively transfect human stem cells and primary cells with minimal cytotoxicity. When applied to genome editing using CRISPR/Cas9 along with single stranded DNA oligonucleotide (ssODN) template in human induced pluripotent stem cells (iPSCs), up to 42.1% HDR rate was achieved, drastically higher than many reported before. We demonstrated that the high HDR efficiency can be utilized to increase the gene ablation rate in cells relevant to clinical applications, by knocking-out β2-microglobulin (B2M) in primary human mesenchymal stem cells (MSCs, 37.3% to 80.2%), and programmed death-1 (PD-1) in primary human T cells (42.6% to 58.6%). Given the generality and efficiency, we expect that the method will have immediate impacts in cell research as well as immuno- and transplantation therapies. | |
dc.format.medium | Electronic | |
dc.language | eng | |
dc.publisher | Springer Nature | |
dc.relation.haspart | ARTN 11649 | |
dc.rights | Licence for published version: Creative Commons Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | CRISPR-Cas Systems | |
dc.subject | DNA End-Joining Repair | |
dc.subject | Electroporation | |
dc.subject | Gene Editing | |
dc.subject | HEK293 Cells | |
dc.subject | Humans | |
dc.subject | Induced Pluripotent Stem Cells | |
dc.subject | RNA, Guide | |
dc.subject | Recombinational DNA Repair | |
dc.subject | Transfection | |
dc.title | Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation | |
dc.type | Article | |
dc.identifier.pmid | 30076383 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174901/2/Efficient homology-directed gene editing by CRISPRCas9 in human stem and primary cells using tube electroporation.pdf | |
dc.identifier.doi | 10.1038/s41598-018-30227-w | |
dc.identifier.doi | https://dx.doi.org/10.7302/6530 | |
dc.identifier.source | Scientific Reports | |
dc.description.version | Published version | |
dc.date.updated | 2022-10-05T15:00:13Z | |
dc.identifier.volume | 8 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 11649 | |
dc.identifier.name-orcid | Xu, X | |
dc.identifier.name-orcid | Gao, D | |
dc.identifier.name-orcid | Wang, P | |
dc.identifier.name-orcid | Chen, J | |
dc.identifier.name-orcid | Ruan, J | |
dc.identifier.name-orcid | Xu, J | |
dc.identifier.name-orcid | Xia, X | |
dc.working.doi | 10.7302/6530 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.